Abstract: TH-OR21
Hb Co-Pilot: Machine Learning Algorithm for Real-Time Hemoglobin Estimation during Hemodialysis and a Multicenter International Validation Trial
Session Information
- Augmented Intelligence and Digital Health Advances
October 24, 2024 | Location: Room 2, Convention Center
Abstract Time: 04:50 PM - 05:00 PM
Category: Augmented Intelligence, Digital Health, and Data Science
- 300 Augmented Intelligence, Digital Health, and Data Science
Authors
- Kuo, Chin-Chi, Big Data Center, China Medical University Hospital, Taichung, Taiwan
- Chen, Sheng-Hsuan, Big Data Center, China Medical University Hospital, Taichung, Taiwan
- Chiang, Hsiu-Yin, Big Data Center, China Medical University Hospital, Taichung, Taiwan
- Sun, Chuan-Hu, Big Data Center, China Medical University Hospital, Taichung, Taiwan
- Hsieh, Mei-Chuan, Big Data Center, China Medical University Hospital, Taichung, Taiwan
- Chou, Che-yi, Asia University Hospital, Taichung, Taiwan
- Holt, Stephen Geoffrey, SEHA Kidney Care, Abu Dhabi, Abu Dhabi, United Arab Emirates
Background
Anemia is linked to premature death among patients receiving hemodialysis (HD). We developed and validated a timely, non-invasive, and simple smartphone APP (Hb Co-Pilot) that captures images of HD dialysis tube and predicts hemoglobin (Hb) level using a machine-learning model.
Methods
Training & Testing Set We enrolled adult HD patients with arteriovenous fistula (AVF) or graft at China Medical University Healthcare System (CMUHS). HD tubing photos on Fresenius 4008(s) machine were taken with a color correction matrix (CCM) on the day of blood testing. A total of 5,453 images were taken by 13 smartphones from 5 HD centers.
Feature Extraction & Modeling Images were pre-processed to ensure similar lighting conditions. We cropped the areas of HD tube and CCM and extracted the 192-dimension vector of image features from both areas by encoding the color information in histograms using a bin size of 64 on each RGB channel. An XGBoost model was used to predict Hb >10 g/dL using image features, age, gender, and last Hb level, with a testing accuracy of 0.93.
Validation Trial CMUHS, Asia University Hospital (AUH) in Taiwan, and SEHA Kidney Care (SKC) in Abu Dhabi participated in our validation trial, with a total of 504 images collected. The targeted area under the receiver operating curve (AUROC) was set to 0.80.
Results
In the validation study, the median age was 62 years, 67% were male, 40% from SKC, 85% had AVF, 26% had Hb ≤10 g/dL, and 40% were taken from Fresenius 5008. The mean of difference between predicted and true Hb was 0.83 g/dL. The AUROC and accuracy was both 0.81, and the sensitivity and positive predictive value both reached 0.87. The F1 and Kappa was 0.87 and 0.50, respectively.
Conclusion
Hb Co-Pilot had robust external validity in Taiwanese and Emirati across different dialysis machines. Model improvement will focus on capturing extreme Hb levels and evaluating its clinical effectiveness.
Funding
- Government Support – Non-U.S.